Article info
Interstitial lung disease
Original research
Minimum important difference of the EQ-5D-5L and EQ-VAS in fibrotic interstitial lung disease
- Correspondence to Dr Christopher J Ryerson, The University of British Columbia Department of Medicine, Vancouver, BC V1Y 1T3, Canada; chris.ryerson{at}hli.ubc.ca
Citation
Minimum important difference of the EQ-5D-5L and EQ-VAS in fibrotic interstitial lung disease
Publication history
- Received April 6, 2020
- Revised August 28, 2020
- Accepted September 2, 2020
- First published October 6, 2020.
Online issue publication
November 09, 2023
Article Versions
- Previous version (15 December 2020).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.